Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 809-852-5 | CAS number: 3395-98-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Justification for type of information:
- Characterization of toxicity profile including target organs after 2 weeks exposure to vapors and clarification of further test strategy. Due to low vapor pressure of test substance, only the technically achievable vapor saturation was tested.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The conduct of inhalation exposures will be performed according to the following test guidelines, OECD Guidelines for Testing of Chemicals, Section 4: Health Effects, No. 412, "Repeated Dose Inhalation
Toxicity: 28-day or 14-day Study" - GLP compliance:
- no
Test material
- Reference substance name:
- 3-ethenyl-5-methyl-1,3-oxazolidin-2-one
- EC Number:
- 809-852-5
- Cas Number:
- 3395-98-0
- Molecular formula:
- C6H9NO2
- IUPAC Name:
- 3-ethenyl-5-methyl-1,3-oxazolidin-2-one
1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH Sulzfeld
- Age at study initiation: 9 weeks
- Housing: wire cage, type DK II, singly
- Diet (e.g. ad libitum): Kliba laboratory diet, mouse/rat maintenance “GLP”, 10 mm pellets, Provimi Kliba SA, Kaiseraugst, Basel Switzerland
- Water (e.g. ad libitum): Drinking water ad libitum
DETAILS OF FOOD AND WATER QUALITY:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30 - 70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- clean air
- Details on inhalation exposure:
- The animals were housed singly in wire cages (DK III) that are located in a glass-steel inhalation chambers, V ≈ 200 L. The inhalation atmospheres are passed into the inhalation chambers with the supply air and are removed by an exhaust air system.
Control group: The exhaust air system is adjusted in such a way that the amount of exhaust air is lower than the supply air (positive pressure). This is to ensure that no laboratory room air reaches the control animals.
Test groups 1: The exhaust air system is adjusted in such a way that the amount of exhaust air is higher than the supply air (negative pressure). This is to ensure that no contamination of the laboratory occurs as the result of leakages from the inhalation chambers. - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 6 hours
- Frequency of treatment:
- each workday (5 times every week), 14 days
Doses / concentrations
- Dose / conc.:
- 18 ppm
- Remarks:
- saturated vapor concentration
- No. of animals per sex per dose:
- 5 animals
- Control animals:
- yes, concurrent vehicle
Examinations
- Observations and examinations performed and frequency:
- Mortality: A check for moribund or dead animals was carried out twice per day on working days and once per day on weekends and holidays.
Symptoms: A clinical inspection was performed on each animal at least three times on exposure days and once a day during pre-exposure and post exposure observation days.
Body weight: The animals were weighed prior to the pre-exposure period, at the start of the exposure period (day 0) and twice weekly thereafter until one day prior to gross necropsy.
Clinical Pathology:
Blood was taken from the retrobulbar venous plexus in the morning from fasted animals using isoflurane as anesthesia. The blood sampling procedure and the subsequent analysis of the blood samples was carried out in a randomized sequence. The list of randomization instructions are compiled with a computer using a random number generator. The following parameters of the animals were examined. Hematology: Leukocytes, Erythrocytes, Hemoglobin, Hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelets, differential blood count, reticulocytes, preparation of blood smears. - Sacrifice and pathology:
- Pathology:
Necropsy: The animals were sacrificed under pentobarbitone anesthesia by exsanguination from the abdominal aorta and vena cava. The animals were necropsied and assessed by gross pathology. Animals which die intercurrently or were killed in a moribund state were necropsied as soon as possible after their death and assessed by gross pathology.
Organ weights:
The following weights were determined in all animals sacrificed on schedule: anesthetized animals, adrenal glands, brain, heart, kidneys, liver, lungs, spleen, testes, thymus.
Organ / Tissue fixation:
The following organs or tissues were fixed in 4% buffered formaldehyde or modified Davidson’s solution: all gross lesions, adrenal glands, brain with olfactory bulb, bone marrow (femur), esophagus, eyes with optic nerve, heart, kidneys, larynx/pharynx, liver, lungs, lymph nodes (tracheobronchial and mediastinal lymph nodes), nose (nasal cavity), ovaries, seminal vesicle, spinal cord (cervical, thoracic and lumbar cords), stomach (forestomach and glandular stomach), spleen, testes (modified Davidson’s solution), thyroid glands, thymus, trachea, urinary bladder, uterus.
From the liver, each one slices of the Lobus dexter medialis and the Lobus sinister lateralis were fixed in Carnoy’s solution and embedded in paraplast. The testes were fixed in modified Davidson’s solution.
The liver and testes of animals that die or will have to be sacrificed intercurrently will be fixed in 4% buffered formaldehyde solution.
Histopathology
All gross lesions, nasal cavity, larrynx, trachea, lungs, lymph nodes, adrenal cortex ,adrenal medulla, bone marrow (femur), brain, esphagus, heart, kidneys, liver, lvaries, ovaries, seminal vesicles, spinal cord, spleen, stomach, testes, thymus, thyroid glands, uterus
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- degeneration/regeneration of the olfactory epithelia at all levels, as well as loss of mucous cells
- Histopathological findings: neoplastic:
- no effects observed
- Other effects:
- no effects observed
- Details on results:
- The mean measured concentration was 18 ppm. In the nasal cavity degeneration/regeneration of the olfactory epithelia was observed at all levels, as well as loss of mucous cells. All other organs were free of any morphological changes.
Effect levels
- Remarks on result:
- other: nasal cavity degeneration/regeneration of the olfactory epithelia was observed at all levels, as well as loss of mucous cells
Applicant's summary and conclusion
- Executive summary:
Five male and five female Wistar rats were whole-body exposed to vapor of 5-methyl-3-vinyl-oxazolidin-2-on for 6 hours a day on 5 days per week for 14 days (10 exposures). Due to low vapor pressure of the test substance, only the vapor saturation concentration was tested. A concurrent control group was exposed to clean air. Clinical inspection for any signs of toxicity was performed three times on exposure days and once daily on exposure-free days. Body weights were determined twice daily, hematology was performed at the end of the exposure period. The whole panel of organs and tissues listed in OECD test guideline 412 underwent histotechnical processing and were examined subsequently by light microscopy. The only effect observed was respiratory irritation in the nasal cavity. All other organs were free of any morphological changes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.